NasdaqGS - Delayed Quote USD

Nautilus Biotechnology, Inc. (NAUT)

2.3600 -0.0400 (-1.67%)
At close: April 25 at 4:00 PM EDT
Loading Chart for NAUT
DELL
  • Previous Close 2.4000
  • Open 2.4000
  • Bid 2.2900 x 100
  • Ask 2.4300 x 100
  • Day's Range 2.3400 - 2.6000
  • 52 Week Range 2.1600 - 4.6500
  • Volume 74,164
  • Avg. Volume 78,348
  • Market Cap (intraday) 295.231M
  • Beta (5Y Monthly) 1.00
  • PE Ratio (TTM) --
  • EPS (TTM) -0.5100
  • Earnings Date Apr 30, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 4.25

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution optical imaging system for integrated fluidics and liquid handling sub-system. In addition, the company provides sample preparation, flow cells, multi-affinity probe reagents, and instrument buffers system to perform multi-cycle analysis runs. Nautilus Biotechnology, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

www.nautilus.bio

167

Full Time Employees

December 31

Fiscal Year Ends

Recent News: NAUT

Performance Overview: NAUT

Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

NAUT
21.07%
S&P 500
5.84%

1-Year Return

NAUT
8.53%
S&P 500
22.03%

3-Year Return

NAUT
79.46%
S&P 500
20.77%

5-Year Return

NAUT
--
S&P 500
50.64%

Compare To: NAUT

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NAUT

Valuation Measures

Annual
As of 4/25/2024
  • Market Cap

    295.23M

  • Enterprise Value

    156.44M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    1.11

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    -2.22

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -14.52%

  • Return on Equity (ttm)

    -21.95%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -63.67M

  • Diluted EPS (ttm)

    -0.5100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    173.42M

  • Total Debt/Equity (mrq)

    13.05%

  • Levered Free Cash Flow (ttm)

    -32.09M

Research Analysis: NAUT

Analyst Price Targets

2.75
4.25 Average
2.3600 Current
5.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: NAUT

Fair Value

2.3600 Current
 

Dividend Score

0 Low
NAUT
Sector Avg.
100 High
 

Hiring Score

0 Low
NAUT
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
NAUT
Sector Avg.
100 High
 

Research Reports: NAUT

  • Daily – Vickers Top Insider Picks for 11/04/2022

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

     
  • Daily – Vickers Top Insider Picks for 11/03/2022

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

     
  • Daily – Vickers Top Insider Picks for 11/02/2022

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

     
  • Daily – Vickers Top Insider Picks for 11/01/2022

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

     

People Also Watch